PRTA
NASDAQ · Biotechnology
Prothena Corp Plc
$7.97
+0.08 (+1.01%)
Open$7.87
Previous Close$7.89
Day High$8.17
Day Low$7.87
52W High$11.80
52W Low$7.73
Volume—
Avg Volume476.9K
Market Cap405.05M
P/E Ratio—
EPS$-0.83
SectorBiotechnology
Analyst Ratings
Buy
12 analysts
Price Target
+69.6% upside
Current
$7.97
$7.97
Target
$13.52
$13.52
$9.22
$13.52 avg
$14.31
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.24M | 16.37M | 162.70M |
| Net Income | -232,792,628 | -371,280,108 | -26,550,677 |
| Profit Margin | -2,520.6% | -2,394.5% | -16.3% |
| EBITDA | -203,848,843 | -343,179,870 | -39,466,979 |
| Free Cash Flow | — | — | -19,760,246 |
| Rev Growth | -43.6% | -43.6% | +13.5% |
| Debt/Equity | — | — | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |